{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:28:35Z","timestamp":1792114115603,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,19]]},"DOI":"10.7759\/cureus.45524","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T09:25:15Z","timestamp":1695115515000},"source":"Crossref","is-referenced-by-count":5,"title":["The Effects of Risperidone on Cognition in People With Autism Spectrum Disorder: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Jhenelle","family":"Hutchinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwa","family":"Folawemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parikshit","family":"Bittla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vani","family":"Sojitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anam","family":"Zahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safeera","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.12788\/cp.0078","article-title":"Pharmacologic management of autism spectrum disorder: A review of 7 studies","volume":"20","author":"Saeed SA","year":"2021","unstructured":"Saeed SA, Hebishi K. Pharmacologic management of autism spectrum disorder: A review of 7 studies. Curr Psychiatr. 2021, 20:33-8. 10.12788\/cp.0078","journal-title":"Curr Psychiatr"},{"key":"ref2","article-title":"Autism","volume":"2010","author":"Parr J","year":"2010","unstructured":"Parr J. Autism. BMJ Clin Evid. 2010, 2010:0322.","journal-title":"BMJ Clin Evid"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-022-00488-4","article-title":"Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis","volume":"13","author":"Siafis S","year":"2022","unstructured":"Siafis S, \u00c7\u0131ray O, Wu H, et al.. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis. Mol Autism. 2022, 13:10. 10.1186\/s13229-022-00488-4","journal-title":"Mol Autism"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005040.pub2","article-title":"Risperidone for autism spectrum disorder","volume":"2007","author":"Jesner OS","year":"2007","unstructured":"Jesner OS, Aref-Adib M, Coren E. Risperidone for autism spectrum disorder. Cochrane Database Syst Rev. 2007, 2007:CD005040. 10.1002\/14651858.CD005040.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-006-0234-7","article-title":"Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial","volume":"37","author":"Pandina GJ","year":"2007","unstructured":"Pandina GJ, Bossie CA, Youssef E, Zhu Y, Dunbar F. Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord. 2007, 37:367-73. 10.1007\/s10803-006-0234-7","journal-title":"J Autism Dev Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199804000-00014","article-title":"An open trial of risperidone in young autistic children","volume":"37","author":"Nicolson R","year":"1998","unstructured":"Nicolson R, Awad G, Sloman L. An open trial of risperidone in young autistic children. J Am Acad Child Adolesc Psychiatry. 1998, 37:372-6. 10.1097\/00004583-199804000-00014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken JT","year":"2002","unstructured":"McCracken JT, McGough J, Shah B, et al.. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002, 347:314-21. 10.1056\/NEJMoa013171","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/070674379403900703","article-title":"Risperidone in the treatment of pervasive developmental disorder","volume":"39","author":"Purdon SE","year":"1994","unstructured":"Purdon SE, Lit W, Labelle A, Jones BD. Risperidone in the treatment of pervasive developmental disorder. Can J Psychiatry. 1994, 39:400-5. 10.1177\/070674379403900703","journal-title":"Can J Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S151802","article-title":"Risperidone for children and adolescents with autism spectrum disorder: a systematic review","volume":"14","author":"Maneeton N","year":"2018","unstructured":"Maneeton N, Maneeton B, Putthisri S, Woottiluk P, Narkpongphun A, Srisurapanont M. Risperidone for children and adolescents with autism spectrum disorder: a systematic review. Neuropsychiatr Dis Treat. 2018, 14:1811-20. 10.2147\/NDT.S151802","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2007.0133","article-title":"Cognitive effects of risperidone in children with autism and irritable behavior","volume":"18","author":"Aman MG","year":"2008","unstructured":"Aman MG, Hollway JA, McDougle CJ, et al.. Cognitive effects of risperidone in children with autism and irritable behavior. J Child Adolesc Psychopharmacol. 2008, 18:227-36. 10.1089\/cap.2007.0133","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2012.0058","article-title":"An open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder","volume":"23","author":"Kent JM","year":"2013","unstructured":"Kent JM, Hough D, Singh J, Karcher K, Pandina G. An open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder. J Child Adolesc Psychopharmacol. 2013, 23:676-86. 10.1089\/cap.2012.0058","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X18666200529151741","article-title":"Effects of risperidone in autistic children and young adults: a systematic review and meta-analysis","volume":"19","author":"Mano-Sousa BJ","year":"2021","unstructured":"Mano-Sousa BJ, Pedrosa AM, Alves BC, Galdur\u00f3z JC, Belo VS, Chaves VE, Duarte-Almeida JM. Effects of risperidone in autistic children and young adults: a systematic review and meta-analysis. Curr Neuropharmacol. 2021, 19:538-52. 10.2174\/1570159X18666200529151741","journal-title":"Curr Neuropharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.7.1361","article-title":"Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months","volume":"162","year":"2005","unstructured":"Risperidone treatment of autistic disorder. longer-term benefits and blinded discontinuation after 6 months. Am J Psychiatry. 2005, 162:1361-9. 10.1176\/appi.ajp.162.7.1361","journal-title":"Am J Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.6.1142","article-title":"Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology","volume":"162","author":"McDougle CJ","year":"2005","unstructured":"McDougle CJ, Scahill L, Aman MG, et al.. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry. 2005, 162:1142-8. 10.1176\/appi.ajp.162.6.1142","journal-title":"Am J Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-012-1689-3","article-title":"Brief report: social disability in autism spectrum disorder: result from research unit on pediatric psychopharmacology (RUPP) autism network trials","volume":"43","author":"Scahill L","year":"2013","unstructured":"Scahill L, Hallett V, Aman MG, et al.. Brief report: social disability in autism spectrum disorder: result from research unit on pediatric psychopharmacology (RUPP) autism network trials. J Autism Dev Disord. 2013, 43:739-46. 10.1007\/s10803-012-1689-3","journal-title":"J Autism Dev Disord"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0040","article-title":"Risperidone added to psychostimulant in children with severe aggression and attention-deficit\/hyperactivity disorder: Lack of effect on attention and short-term memory","volume":"27","author":"Farmer CA","year":"2017","unstructured":"Farmer CA, Epstein JN, Findling RL, et al.. Risperidone added to psychostimulant in children with severe aggression and attention-deficit\/hyperactivity disorder: Lack of effect on attention and short-term memory. J Child Adolesc Psychopharmacol. 2017, 27:117-24. 10.1089\/cap.2016.0040","journal-title":"J Child Adolesc Psychopharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/181668-the-effects-of-risperidone-on-cognition-in-people-with-autism-spectrum-disorder-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:10Z","timestamp":1707508450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/181668-the-effects-of-risperidone-on-cognition-in-people-with-autism-spectrum-disorder-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.45524","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,19]]}}}